Abstract
Calcineurin (CaN), a Ca2+/calmodulin-activated serine/threonine phosphatase, acts as a Ca2+-sensitive switch regulating cellular functions through protein dephosphorylation and activation of gene transcription. In astrocytes, the principal homeostatic cells in the CNS, over-activation of CaN is known to drive pathological transcriptional remodelling, associated with neuroinflammation in diseases such as Alzheimer’s disease, epilepsy and brain trauma. Recent reports suggest that, in physiological conditions, the activity of CaN in astrocytes is transcription-independent and is required for maintenance of basal protein synthesis rate and activation of astrocytic Na+/K+ pump thereby contributing to neuronal functions such as neuronal excitability and memory formation. In this contribution we overview the role of Ca2+ and CaN signalling in astroglial pathophysiology focusing on the emerging physiological role of CaN in astrocytes. We propose a model for the context-dependent switch of CaN activity from the post-transcriptional regulation of cell proteostasis in healthy astrocytes to the CaN-dependent transcriptional activation in neuroinflammation-associated diseases.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Astrocytes represent a logistic arm of the CNS, assuming full homeostatic control over the CNS development and functions [1, 2]. In all these activities Ca2+ signals are thought to play important roles [3,4,5,6]. During the last two decades significant progress has been made in understanding the spatio-temporal properties of Ca2+ signals in astrocytes and their role in synaptic plasticity, memory, cognition, sleep and behaviour [3, 7,8,9,10,11,12,13,14,15]. This progress regarded mainly the properties and roles of Ca2+ signals themselves, while little was known about astrocyte-intrinsic mechanisms of decoding Ca2+ signals and their mechanistic link with homeostatic and signalling events in astrocytes [4]. The importance of such signalling for cell physiology can be exemplified by the role of two Ca2+-sensitive switches, CaMKII and CaN, in neuronal physiology, including synaptic plasticity and memory [16,17,18]. In astrocytes, CaMKII has been mainly studied in vitro (reviewed in [4]). CaN expression and activation in astrocytes has been detected both in vitro and in vivo and has mainly been studied in association with its downstream inflammation-related targets, transcription factors NFAT and NF-kB, in pathological conditions [19,20,21]. Recently, it has been suggested CaN may participate in short- and long-lasting morpho-functional changes that astrocytes undergo during neuronal activity, so called astrocytic plasticity [21]. Shortly after, evidence has been provided that CaN in astrocytes are not only implicated in the development of reactive gliosis and neuroinflammation, but have also a role in astrocytic physiology, opening to the possibility that Ca2+ and CaM-regulated molecular switches are important for astrocytic functions, albeit by different mechanisms [22, 23]. In this contribution we review i) astrocytic Ca2+ signalling in the context of CaN activation; ii) the role and mechanisms of CaN overactivation in neuropathological conditions; and iii) the mechanisms of CaN regulation of astrocytic homeostatic and signalling functions.
Astroglial Ca2+ Signaling: An Overview
Astroglial Ca2+ Signaling Toolkit
Astrocytes do not generate action potentials and therefore are considered to be non-excitable cells, although the expression of voltage-gated ion channels in astrocytes has been demonstrated [2]. Ligand-operated signaling through ionotropic or metabotropic receptors, linked to the release of Ca2+ from internal stores, represents for astrocytes the main mean of signal transduction [4, 24]. Therefore, the ER membrane (endomembrane) represents an excitable media and Ca2+ is the substrate for the astrocytic excitability [25, 26]. Astrocytes express an array of metabotropic receptors linked to trimeric G-proteins containing Gαq/11, which, through activation of PLCβ, hydrolyze PIP2 to generate the diffusible second messenger IP3. IP3 act on IP3-sensitive ligand-gated channels (IP3Rs) located on the endomembrane allowing a controlled release of Ca2+ from the ER and related organelles, such as the Golgi apparatus [27,28,29,30,31,32]. IP3R is coded by three genes, ITPR1-3, resulting in three protein isoforms, IP3R1-3, respectively, with multiple splice variants [33]. Although all three isoforms have been found in astrocytes at mRNA level, two of them, namely IP3R1 and IP3R2 have been mainly implicated in Ca2+ release from the ER [14]. IP3R2 is thought to be the most abundant IP3 receptor. It mediates Ca2+ release from the ER in the cell soma, main and secondary astrocytic processes, named as branches and branchlets, respectively [4, 14]. Astrocyte-specific KO of IP3R2 abrogated the majority of massive, high amplitude Ca2+ signals, but not peripheral local small amplitude Ca2+ events. Therefore, it is thought that IP3R2 is responsible for the global Ca2+ response and for spreading of intracellular Ca2+ waves through the astrocyte. Instead, IP3R1 has been found in peripheral processes and in peri-synaptic processes, where it mediates local Ca2+ signals [13, 14, 34].
Ca2+ entry may occur through a number of ligand-gated channels which include glutamate-sensitive NMDA receptors, purinergic P2X7 receptors, dopamine D1/D2 receptors, α7-containing nicotinic acetylcholine receptors, which are expressed in a brain region-specific manner. Store-operated Ca2+ channels, activated in response to ER Ca2+ depletion, include Orai and TRP channels. STIM serves as an ER luminal Ca2+ sensor and transduces the change of the ER [Ca2+] to the plasma membrane. It has been suggested, in astrocytes, that TRPC channels (isoforms 1, 3 and 5) play a major role in SOCE [2, 4].
Ca2+ dynamics in astrocytes are tightly coupled with Na+ fluxes. The coordinating role of NCX in Ca2+-Na+ signaling interplay has been extensively discussed [35]. Functional role and Ca2+ entry mechanism in vivo is not completely understood and this field currently is under intensive investigation [36,37,38].
Complexity and Diversity of Astrocytic Ca2+ Signals
Astrocytes display a remarkable diversity of cytosolic Ca2+ signals, which can roughly be divided in global Ca2+ events and local propagating or non-propagating Ca2+ events. In situ and in vivo astrocytes generate frequent spontaneous Ca2+ signals, which occur locally in branches, branchlets and endfeet, and are independent on somatic IP3R2-dependent Ca2+ signals. Local Ca2+ signals may originate from (i) IP3R1-mediated Ca2+ release; (ii) Ca2+ influx through ligand-gated Ca2+ channels, TRP channels or reverse mode acting NCX; (iii) controlled Ca2+ efflux from mitochondria through mitochondrial permeability transition pore or from Na+/Ca2+/Li+ exchanger NCLX. Spontaneous Ca2+ events are likely to represent, or respond to the changes of metabolic or RedOx states of astrocytes. Triggered Ca2+ events can be evoked in response to neuronal activity as well as a part of propagating inter-cellular Ca2+ wave [4, 8, 12, 15, 39, 40].
Technological advances in fast volumetric imaging have allowed recording of three-dimensional Ca2+ signals with high speed [41]. These measurements have confirmed a rich repertoire of spontaneous and evoked Ca2+ signals in astrocytes, highlighting their spatio-temporal complexity and emphasizing the challenges in their detection and interpretation [12, 40, 42].
Functional Significance of Ca2+ Signals in Astrocytes: The State of the Art
Ca2+ signals are implicated in the regulation of a plethora of cellular functions and the overarching question in the field regards their functional significance [3, 4, 6]. Functionally, Ca2+ signaling in astrocytes can be generally divided in two categories: (1) ‘domestic’ signaling and (2) astrocyte functions-specific signaling (Fig. 1). Domestic homeostatic Ca2+ signaling regulates activities, common to most cells, such as (i) maintenance of Ca2+ homeostasis itself, (ii) secretion [43], (iii) protein synthesis and degradation [44], (iv) gene transcription [45,46,47], (v) proliferation and cellular motility [48, 49] and (vi) metabolism and bioenergetics [50]. Being homeostatic cells in the CNS, astrocytes use Ca2+ signals for sensing the environment and for translation of the environmental changes into homeostatic and signaling activities. Therefore, ‘domestic’ Ca2+ signaling is subordinated to the inter-cellular astrocytic responses during communication with other cells in the CNS.
Astrocyte-specific functions of Ca2+ signaling are thought to participate in the CNS activities at several levels, the lowest level being the control over synaptic transmission at the tripartite synapse. The next level may be represented by the control of synaptic and neuronal circuits through participation in the establishment of so called ‘guiding templates’—supra-cellular spatio-temporal patterns of signaling molecules which ‘guide’ the excitation flow in the neuronal networks. The next level of complexity may be represented by the control over systemic blood flow, respiratory control, locomotion, sleep and higher brain functions including memory formation and cognition (reviewed in [3, 12, 39, 51, 52]. All these levels have been experimentally tested for being controlled directly by astrocytic Ca2+ signals, mainly through the release of neuro- or vaso-active gliotransmitters and control of the ionic composition of the extracellular milieu.
However, many functions are likely to be controlled by Ca2+ indirectly, therefore, Ca2+ signals need to be ‘decoded’ and translated into modulation of protein activities, signaling events, metabolic reactions, or gene transcription events. Such Ca2+ ‘decoders’, represented by a limited group of Ca2+-binding proteins including CaMKII, CaN, Ca2+-activated adenylate cyclase, DREAM etc., have been studied in neurons [16, 45, 47, 53, 54], while in astrocytes there is a significant gap in knowledge. Recently, CaN has been identified as a physiologically relevant Ca2+ sensitive switch to drive the most important astrocytic activities [22, 55].
Calcineurin Structure, Activation and Protein Binding
Calcineurin Structure and Activation
CaN has been discovered in the late seventies as one of the most abundant proteins in the CNS [56, 57]. While highly enriched in neurons and in lymphoid cells, however, CaN is ubiquitously expressed in most cellular types, including astrocytes. Structurally, CaN is a heterodimer composed of one catalytic subunit (∼60 kDa, known as calcineurin A or CaNA) and one regulatory subunit (∼19 kDa, known as calcineurin B or CaNB). In mammals, three isoforms of CaNA have been identified: α, β and γ [58, 59]. The isoforms α and β are ubiquitously distributed, while the expression of γ isoform is restricted to testis. Three functional domains can be identified in the CaNA sequence: N-terminal globular catalytic domain, CaNB binding domain, and C-terminal tail containing a domain binding Ca2+/CaM complex (calmodulin-binding domain, CaMBD) and an autoinhibitory domain.
Two isoforms of CaNB have been identified (CaNB1 and CaNB2), with CaNB1 found to be expressed in the CNS [60]. CaNB is indispensable for the catalytic activity of CaNA, therefore its genetic deletion has been widely used to knock-out CaN in different tissues and organs. Cell-specific deletion of CaB1 has been used to ablate CaN activity in neurons and astrocytes [22, 61]. The CaNB possesses four EF-hands Ca2+ binding domains [62]. The first 2 EF-hands at the N-terminal lobe serve as low affinity Ca2+-sensing motifs, while the other 2 EF-hands at the C-terminal lobe bind Ca2+ with high affinity with a constant of dissociation (Kd) in the nanomolar range (30–150 nM for purified CaNB) [63]. The low affinity motifs have a regulatory role serving as sensors of the calcium fluctuations, whereas the high affinity motifs on the C-terminal lobe serve for stabilization of the heterodimer [64, 65].
In the inactive state, CaNB interacts with CaNA through N-terminal lobe, while its C-terminal lobe is loosely bound (or unbound) to the catalytic subunit. It is thought that at resting conditions the high affinity Ca2+-binding sites on the C-terminal lobe of CaNB are saturated with Ca2+ and this serves for stabilization of the CaNB-CaNA interaction. C-terminal tail of CaNA, containing CaMBD and autoinhibitory domains, is folded and interacts with CaNA catalytic site and with CaNB-binding part, impeding the interaction of substrate proteins with the catalytic site [66].
Activation of CaN has been postulated to occur in two steps. Firstly, upon elevation of cytosolic [Ca2+], Ca2+ binds to the low affinity Ca2+-binding sites at the N-terminal lobe of CaNB. This induces the displacement and unfolding of CaMBD and its conversion to a disordered state. This allows the interaction between the C-terminal lobe of CaNB and CaNA, and exposes the CaMBD to Ca2+/CaM complex. This state is considered as partially active and can be maintained in the absence of CaM. Subsequent binding of Ca2+/CaM complex to CaMB promotes the displacement of the autoinhibitory domain from the catalytic site of CaNA, resulting in full activation of CaN [65, 67]. Recent reports suggest that the displacement of the AID from the catalytic site requires CaM binding to the sites outside the CaMBD [68, 69].
CaN Interaction with Proteins
Most of the knowledge on CaN binding to its substrates has been gathered studying CaN interaction with the NFAT transcription factors family [70]. Two substrate-interaction sites have been identified in the CaN holoenzyme. The PxIxIT-binding pocket is located on the side surface of the N-terminal lobe of CaNA subunit. The second site, the LxVP-binding pocket, is formed at the interface of CaNA and CaNB interaction. The PxIxIT and LxVP pockets are named after corresponding CaN-binding motifs of NFAT transcription factors family [70]. The PxIxIT pocket is accessible to CaN-binding proteins in both inactive and activated CaN states and is thought to mediate CaN-protein interaction in resting condition. Hypothetically, proteins binding to the PxIxIT pocket is possible in the absence of the regulatory CaNB subunit. In resting conditions the LxVP pocket is blocked by the interaction with CaMBD and is not accessible for CaN-binding proteins. Upon deletion of CaNB subunit, the LxVP pocket is disrupted and this leads to permanent inactivation of phosphatase CaN activity. This suggests that the substrate binding to the LxVP pocket is essential for the catalytic CaN holoenzyme activity. This conclusion is supported by the constitutive and Ca2+-independent CaN holoenzyme activation upon proteolytic cleavage of the C-terminal tail of CaNA containing CaMBD and AID. This also suggests that Ca2+ binding to CaNB is necessary exclusively for the displacement of the CaMBD and AID and does not affect catalytic activity of CaNA.
It has also been shown that the LxVP and PxIxIT motifs bind jointly to overlapping epitopes on CaNA catalytic domain distant to the regulatory domain suggesting that the ratio and the affinities of LxVP and PxIxIT motifs to CaNA define the occupancy of peptide-binding sites on CaNA [71].
During the last decade, the CaN-protein interaction field experienced a significant progress due to in silico identification of putative CaN-interacting peptides called short linear motifs (SLiMs). Hundreds of new CaN-interacting proteins have been identified containing SLiMs similar to canonical PxIxIT and LxVP motiffs and novel inhibitors of CaN signaling have been generated [72,73,74,75,76,77]. The results of these investigation suggest that: (i) binding of a protein to CaN does not automatically mean its de-phosphorylation, some CaN-binding proteins provide a scaffold for the CaN interaction with its substrates; (ii) PxIxIT- and LxVP-like motifs of CaN-binding proteins may differ from the canonical motifs, differing also in the affinity to the relative protein binding pockets on CaN; (iii) in many CaN substrates only one of two CaN binding motifs, either PxIxIT- or LxVP-like SLiM, has been identified. Considering the requirement of two-site interaction for dephosphorylation activation, this suggests the presence of yet not identified degenerated CaN-binding motifs. Otherwise, this suggests that, in certain conditions, the one-site interaction is sufficient to promote the catalysis of dephosphorylation.
Based on the above considerations and on recent reports, the following variables may define the catalytic CaN activity towards specific substrates in the intracellular environment: (i) expression levels and localization of CaNA and CaNB subunits and isoforms; (ii) spatio-temporal pattern of Ca2+ signals defined as a combination of spatial (global, local or in specific sub-cellular compartments) and temporal (amplitude, frequency and the duration of Ca2+ signals) properties [78]; (iii) intracellular distribution and concentration of CaM [79]; (iv) intracellular distribution and concentration of CaN-binding proteins, competing for binding to CaN in function of the presence and affinity of their CaN-binding motifs; (v) intracellular distribution and levels of endogenous CaN inhibitors, such as RCAN [80,81,82]; (vi) pathology-related constitutive activation of CaN upon cleavage by Ca2+-activated proteases [83, 84].
Pathology of Astroglial Calcium and Calcineurin Signaling
Astrocytic Ca2+ signals have been shown to be altered in vitro and in vivo in many cell and animal models of neurodegenerative diseases with a general consensus on chronic cellular Ca2+ overload. In the last decade, the topic has been covered by a number of reviews and is outside the scope of this contribution [85,86,87,88,89,90,91,92,93]. CaN pathology in astrocytes has mainly been documented and studied in cerebro-vascular disorders, Alzheimer’s disease (AD) and brain trauma [19,20,21, 94, 95]. In response to chronic Ca2+ overload, both over-expression of CaN and its over-activation by calpain-mediated cleavage of the autoinhibitory Ca2+/CaM-binding tail leads to the activation of inflammation-related NFAT and NF-kB signaling. NFAT is a direct target of CaN studied in detail in immune cells [96]. In astrocytes, CaN/NFAT-mediated activation of transcriptional reprogramming towards reactive gliosis and neuroinflammation has been observed in AD models and in AD human brains [97]. In this context, the importance of astrocyte-specific CaN/NFAT signaling for the development of neuroinflammation and neuronal dysfunction, both in acute and chronic brain diseases, has been proved through molecular uncoupling of CaN from NFAT by VIVIT peptide representing a variant of CaN binding site of NFAT, optimized to bind CaN with high affinity [98,99,100].
There is an ample evidence of the role of NF-kB in astroglial physiology and pathology [101,102,103]. In astrocytes, interaction of CaN with NF-kB signaling occurs at several levels: (i) at the level of the ternary complex between Bcl10, MALT1 and CARMA1, in which Aβ-induced CaN dephosphorylation of Bcl10 positively regulates NF-kB signaling [104]; (ii) CaN dephosphorylates IkBα, thus precluding its degradation which inhibits NF-kB nuclear translocation in culture in response to anti-inflammatory action of IGF-1 [105]; (iii) CaN, in complex with NF-kB and FOXO3, is required for TNFα- induced NF-kB nuclear translocation and activation of transcription [106, 107]. The final outcome in terms of NF-kB-mediated transcriptional activation and neuroinflammatory reaction appears to be stimulus- and context-dependent, specifically, dependent on the presence of microglial cells. E.g., regulated expression of constitutively active calcineurin in astrocytes markedly reduced inflammatory injury in transgenic mice [108], while in purified cultures of hippocampal astrocytes pro-inflammatory stimuli, such as TNF, Il1β or LPS, promoted IkB degradation and NF-kB activation [109].
The therapeutic potential of CaN inhibition is exemplified by reports showing that systemic treatment of mice with CaN inhibitors mitigate neuropathology and behavior [110, 111]. Furthermore, in humans it has been shown that patients with solid organ transplants and treated with immunosuppressant CaN inhibitors for prevention of the organ rejection have a reduced risk to develop dementia [112]. This is in spite of the prior co-morbid conditions predisposing to the development of neurodegenerative diseases [112].
Taken together, the above reports suggest that overexpression and over-activation of CaN in astrocytes is required for their transition from healthy to reactive phenotype and for development of neuroinflammation.
Physiology of Astroglial Calcineurin Signaling
Until recently little was known about physiological role of CaN in astrocytes, as CaN activation only reported in pathological conditions. A proof of principal study was published five years ago showing that CaN in astrocytes can be robustly activated in mixed astrocyte-neuron hippocampal primary cultures in response to chemical induction of LTP [23], showing that in principle, astrocytic CaN can be activated during neuronal activity. Further work on an astrocyte-specific conditional CaN KO (ACN-KO mice) showed that the spectrum of physiological activities of CaN in astrocytes differs from that in brain pathology as it does not involve transcriptional remodeling of astrocytes [22, 55].
Control of Neuronal Excitability
It has been found that ACN-KO mice show a severe impairment of excitability of cerebellar granule cells and hippocampal pyramidal neurons. It has been suggested that this impairment is due to functional inactivation of astrocytic Na /K+ ATPase (NKA) and inability of astrocytes to clear K+ from external space resulting in prolongation of the neuronal hyperpolarization and extension of the refractory period [22]. This conclusion has been corroborated by the inhibition of neuronal excitability by NKA inhibitor ouabain. Extracellular K+ buffering, the most archetypal homeostatic task of the astrocytes, initially attributed to the activity of Kir4.1 channels, has been demonstrated to occur through astrocytic NKA [113, 114]. It has been shown that there is an active low affinity and high capacity K+ uptake by the astrocyte-specific NKA isoform, composed of α2β2 isoforms [115, 116]. These data highlight the role of astroglial NKA in K+ clearance [116].
Another hint that astroglial CaN is implicated in control of neuronal excitability comes from the finding that in ACN-KO astrocytes the release of glutamate was inhibited in concomitance with the upregulation of astrocyte-specific glutamate transporter GLAST [22, 117]. Astrocytic control over the ambient glutamate concentrations is important for the extrasynaptic NMDA receptor tone, which is paramount for the excitability of neuronal networks and for the balance between excitation and inhibition [118]. The deficiency of astrocytic glutamate transport leads to neuronal hyper-excitability which has been associated with epileptic seizures and pathological conditions [119, 120].
It has been found that, from 5–8 months of life, ACN-KO mice show an elevated risk to develop epileptic seizures [55]. At the age of 12 months about 50% of mice, both males and females, showed at least one seizure event. Because of the onset of Cre recombinase expression in astrocytes of ACN-KO mice, hence CaN KO, occurs very early in mouse ontogenesis (from the second postnatal week), it is unlikely that seizure are the direct effect of CaN inactivation. Rather, the several months lag between CaN KO and seizure events suggests that chronic deficiency of CaN activity in astrocytes leads to compensatory or dis-compensatory reactions which in turn result in neuronal hyper-excitability and seizures.
In summary, data suggest that the acute CaN deficiency results in neuronal hypo-excitability, while chronic CaN ablation leads to hyper-excitability. Further experiments are needed to dissect mechanistic cascade leading from CaN ablation to hyper-excitability and seizures.
Control of Spatial Memory
Using Barnes maze paradigm of spatial memory assessment, it has been shown that ACN-KO mice do not have spatial memory impairment, i.e., they learn the position of the escape box [55]. However the way they find the box was drastically different from ACN-WT mice. ACN-WT mice use direct search using spatial queues to locate the escape box position. Instead, ACN-KO mice use serial search, which is a spatial queue-independent strategy consisting in sequential exploring holes until the right hole with the escape box is found [55]. Interestingly, the improvement of the primary latency (e.g., time to approach the hole) and the entry latency (time to enter the escape box) over the sessions was not different between ACN-WT and ACN-KO mice. i.e., ACN-KO mice remember the existence of the escape box and maintain the motivation to find it, but are likely unable to use spatial queues to locate the box (Fig. 2A). Strikingly, similar effect, i.e. use of serial instead of direct search strategy in Barnes maze learning paradigm, was reported in mice expressing Ca2+-insensitive mutants of CaMKII [121]. Later, it was suggested that hippocampus is used for non-spatial memory processing due to its ability to time-parse elementary memory events to integrate temporal (when), episodic (what), spatial (where) information into memory traces [122, 123]. In light of this view it is plausible to conclude that ACN-KO mice fail to develop spatial search and avail to serial exploration of holes due to functional dissociation of temporal and spatial representations both of which are hippocampus-dependent [122]. Interestingly, such a dissociation has been found in the hippocampus of an AD mouse model, rTg4510 mice, in which temporal sequences of neuronal firing can persist while spatial firing is disrupted [124]. The loss of the ability to use spatial (direct) search was found in different model of AD and epilepsy [125, 126].
While the link between astrocytic CaN and neuronal CaMKII at present is not clear, we hypothesized that, if there is a link, the expression of immediate early genes (IEGs), activated downstream CaMKII in response to the ambient stimulus, may be affected [127,128,129]. Indeed, we found that the induction of IEGs at the first exposure of mice to Barnes maze and at the end of training sessions, was changed oppositely: at the first exposure there is a significantly enhanced mRNA expression of Egr1 and Egr2 in ACN-KO mice compared with ACN-KO mice, while after the last session of the learning paradigm the induction of all four IEGs tested (c-Fos, Arc, Egr1 and Egr2) was completely suppressed in ACN-KO mice (Fig. 2B). While the mechanistic explanation of such effects requires further investigation, one could speculate that the mechanisms may include (i) altered mechanisms of memory consolidation which requires expression of IEGs [130]; (ii) astrocytic control of neuronal protein synthesis, discussed in the next section, and (iii) the link between neuronal excitability, found to be impaired in ACN-KO mice [22], and the activity of CaMKII in neurons [131].
Post-Transcriptional Control of Protein Synthesis
RNA-sequencing of hippocampal and cerebellar tissues from 1 month-old ACN-KO mice showed no background astrocytic CaN-dependent transcriptional activity in the CNS [55]. Only two genes were found to be differentially expressed in hippocampus and cerebellum (Rab31 and Vapa, in hippocampus and Dsp and Rab31 in the cerebellum). This was in striking contrast to what is known about astrocytic CaN activity in pathology-related gliosis and neuroinflammation [19, 95], suggesting that, in resting condition in healthy CNS, CaN in astrocytes does not regulate gene transcription. However, it should be clarified that such transcriptional inactivity specifically regards non stimulated resting conditions. Instead, reports suggest that CaN-mediated NFAT activation and gene transcription may occur in response to neuronal activity. First, chemical activation of neuronal activity in vitro induced robust nuclear translocation of overexpressed NFAT-GFP probe into the nucleus, suggesting that neuronal activity stimulates CaN interaction with and dephosphorylation of NFAT [23]. In this frame, early report had demonstrated that in both astrocytes and pericytes of rat cortical brain slices electrical field stimulation induced CaN-dependent nuclear translocation of NFATc3 [132]. Together, these reports suggest that neuronal activity may stimulates CaN-dependent NFAT activation and, in principle, gene transcription, although functional consequences of such activation is yet to be investigated.
Further assessment of protein expression by shotgun mass spectrometry proteomics revealed massive changes in protein expression profile both in the hippocampus and cerebellum suggesting that the activity of CaN in astrocytes is directed towards regulation of posttranscriptional protein synthesis [55]. Several features make ACN-KO hippocampal and cerebellar proteomes unique with a clear association to neuropathology.
First, astrocyte-specific deletion of CaN affected protein expression in all CNS cellular types, including neurons, astrocytes, microglia and endothelial cells, with the major part of the differentially expressed proteins being neuron-specific or enriched in neurons, while there were only a few astrocyte-specific proteins. This suggests that CaN activity in astrocytes is important for the maintenance of proteostasis not only in astrocytes themselves, but in the entire CNS, which may reflect the archetypal homeostatic functions of astrocytes. Such a control may be exerted, e.g., through the control over extracellular glutamate levels [22, 117]. There is a firm association between synaptic and extra-synaptic glutamate in the CNS and protein synthesis and degradation in neurons [133,134,135].
Second, gene ontology analysis suggest that the major impact of CaN deletion from astrocytes is on protein synthesis and mitochondria [55]. Both disproteostasis and mitochondrial dysfunction are early alterations of many neurodegenerative and neurological diseases, and are interdependent phenomena [136, 137]. In vitro experiments on mouse and human astrocytic primary cultures suggest that inhibition of CaN results in a biphasic alteration of protein synthesis of selected proteins. Thus, GLAST was downregulated upon acute CaN inhibition, while chronic CaN inhibition results in GLAST upregulation and a reduction of extracellular glutamate [22, 117]. Moreover, CaN inhibition affected both protein synthesis and protein degradation [117]
Third, signaling pathway analysis using IPA suggested that hypothetical upstream regulators of the changes found in ACN-KO mouse hippocampus could be the AD-causing proteins MAPT, APP and PSEN and HD-causing HTT [55]. Because of the observed proteome alterations in ACN-KO mice, that are the result of the deletion of CaN from astrocytes, it is plausible to speculate that similar CaN dysfunction may occurs in neurodegenerative disease, specifically in AD. Further confirmation of this speculation is found in a significant overlap between the ACN-KO hippocampal proteome and the proteome of 5xFAD mice at early symptomatic stage: of 18 proteins found to be common in two datasets, 13 were co-regulated, 8 were co-upregulated and 5 were co-downregulated, suggesting that alterations of CaN activation in astrocytes may represent a common element [55, 138, 139].
CaN regulation of protein synthesis and degradation machineries may involve several mechanisms. At the level of ribosomal translational machinery, at least four factors, eukaryotic translation initiation factor 2B (eIF2B), eukaryotic translation initiation factor 4E binding protein 1 (4EBP1), eukaryotic translation initiation factor 4F (eIF4F) and eukaryotic translation elongation factor 2 (eEF2), have been suggested to be directly regulated by CaN [140]. Lysosomal protein degradation and autophagy have also been associated with CaN activity [141,142,143]. ER stress/unfolded protein response (UPR) is a stereotyped cellular reaction to stress, triggered by the accumulation of misfolded/aggregated proteins along the secretory pathway and/or by the ER Ca2+ dyshomeostasis [144]. There is ample evidence for the role of CaN in ER stress/UPR-associated disproteostasis [145,146,147,148,149,150].
A Model for a Switch in CaN Activity in Astrocytes from Physiology to Pathology
Based on the above discussed, we hypothesize that, in astroglial cells, the spectrum of CaN-binding partners as well as substrates for dephosphorylation may change during the transition from healthy CNS environment to pathological states, such as reactive astrogliosis-related and unrelated alterations. The model includes three main states (columns B-D in Fig. 3). First, in healthy CNS CaN in astrocytes does not interact with transcription factors, such as NFAT or NF-kB, and does not exert significant transcriptional regulation. Instead, CaN activity is required to maintain basal protein synthesis rate and degradation at the posttranscriptional level, perhaps regulating ribosomal protein synthesis and proteasomal protein degradation. The second state considers the deficiency of CaN activity due to alterations in Ca2+ and/or CaM signaling in response of both intrinsic and extrinsic factors which leads to disproteostasis with signatures of neuropathologies such as AD and epilepsy. Importantly, in the second state the disproteostasis does not involve activation of NFAT or NF-kB or other inflammation-related transcription factors and does not immediately result in astrocytic activation and/or neuroinflammation. This second state is based on the experiments with CaN deletion or pharmacological inhibition, it is speculative and requires experimental prove. Nevertheless, it may provide a framework for further investigation of astrocytic CaN dysfunction at early stages of neuropathologies. The third state considers the consolidated over-activation of CaN and activation of CaN → NFAT/NF-kB pathways with consequent transcriptional remodeling and development of neuroinflammation, described in a number of experimental and human pathologies including AD, epilepsy and brain trauma. This, terminal, CaN activation involves: (i) chronic overload of the cell with Ca2+ which generates non-physiological Ca2+ signal for CaN activation; (ii) overexpression of CaM, CaN subunits and substrates such as CaNA and NFAT; and (iii) CaN cleavage of Ca2+-activated proteases and generation of Ca2+ and CaM-independent constitutively active CaN species. An important implication of the proposed model is represented by the change of the CaN-binding partners during the transition from physiological to pathological states (Fig. 3). Identification of CaN-binding proteins and substrates in healthy and diseased astrocytes will be determinant for understanding the physio-pathology of astrocytic CaN signaling.
Conclusions and Future Directions
In astrocytes, the canonical view on CaN signaling considers the activation of pro-inflammatory CaN → NFAT/NF-kB axes governing astrocytic transcriptional remodeling in pathological conditions [19, 21, 95]. Recent reports from our lab challenged this paradigm, suggesting that in healthy astrocytes transcription-independent CaN activity is required for maintenance of basal protein synthesis possibly through dephosphorylation of eIF2α, thereby regulating astrocytic and neuronal functions such as neuronal excitability and memory formation [22, 55, 117, 151]. To provide a framework for further investigation of the role and mechanisms of activation of CaN in astrocytes in physiology and pathology, we propose a model of the transition of astrocytic CaN from the transcription-independent functions in healthy CNS to the activation of CaN → NFAT/NF-kB-mediated transcriptional reprograming in diseases accompanied by neuroinflammatory reaction. The transition may include a context-dependent switch of CaN binding protein partners. To assess the validity of this model and deepen our knowledge about physiological role of astroglial CaN, further experiments are necessary addressing following issues: (i) identification of CaN-binding partners and substrates in physiological and in astrogliosis/neuroinflammation-related conditions; (ii) characterization of synaptic connectivity and plasticity in mice bearing CaN KO in astrocytes; (iii) detailed characterization, in ACN-KO mice, of functions related to maintenance of CNS homeostasis such as neurotransmitter, water and electrolyte, metabolic homeostasis; (iv) investigation of transition from transcription-inactive to transcription competent CaN states; (v) better phenotypic and mechanistic characterization of delayed alterations in mice with astrocytic CaN KO, such as epileptic seizures and concomitant neuroinflammation.
Data Availability
This review paper contains no datasets.
References
Verkhratsky A, Nedergaard M (2016) The homeostatic astroglia emerges from evolutionary specialization of neural cells. Philos Trans R Soc Lond, B, Biol Sci. https://doi.org/10.1098/rstb.2015.0428
Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98:239–389. https://doi.org/10.1152/physrev.00042.2016
Khakh BS, Sofroniew MV (2015) Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18:942–952. https://doi.org/10.1038/nn.4043
Lim D, Semyanov A, Genazzani A, Verkhratsky A (2021) Calcium signaling in neuroglia. International Review of Cell and Molecular Biology. Academic Press, Elsevier
Parpura V, Verkhratsky A (2012) Homeostatic function of astrocytes: Ca2+ and Na+ signalling. Transl Neurosci 3:334–344. https://doi.org/10.2478/s13380-012-0040-y
Santello M, Toni N, Volterra A (2019) Astrocyte function from information processing to cognition and cognitive impairment. Nat Neurosci 22:154–166. https://doi.org/10.1038/s41593-018-0325-8
Bazargani N, Attwell D (2016) Astrocyte calcium signaling: the third wave. Nat Neurosci 19:182–189. https://doi.org/10.1038/nn.4201
Khakh BS, McCarthy KD (2015) Astrocyte calcium signaling: from observations to functions and the challenges therein. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a020404
Kjaerby C, Rasmussen R, Andersen M, Nedergaard M (2017) Does global astrocytic calcium signaling participate in awake brain state transitions and neuronal circuit function? Neurochem Res 42:1810–1822. https://doi.org/10.1007/s11064-017-2195-y
Oheim M, Schmidt E, Hirrlinger J (2018) Local energy on demand: are “spontaneous” astrocytic Ca2+-microdomains the regulatory unit for astrocyte-neuron metabolic cooperation? Brain Res Bull 136:54–64. https://doi.org/10.1016/j.brainresbull.2017.04.011
Rusakov DA (2015) Disentangling calcium-driven astrocyte physiology. Nat Rev Neurosci 16:226–233. https://doi.org/10.1038/nrn3878
Semyanov A, Henneberger C, Agarwal A (2020) Making sense of astrocytic calcium signals—from acquisition to interpretation. Nat Rev Neurosci 21:551–564. https://doi.org/10.1038/s41583-020-0361-8
Sherwood MW, Arizono M, Hisatsune C et al (2017) Astrocytic IP3 Rs: contribution to Ca2+ signalling and hippocampal LTP. Glia 65:502–513. https://doi.org/10.1002/glia.23107
Sherwood MW, Arizono M, Panatier A et al (2021) Astrocytic IP3Rs: beyond IP3R2. Front Cell Neurosci 15:695817. https://doi.org/10.3389/fncel.2021.695817
Shigetomi E, Patel S, Khakh BS (2016) Probing the complexities of astrocyte calcium signaling. Trends Cell Biol 26:300–312. https://doi.org/10.1016/j.tcb.2016.01.003
Baumgärtel K, Mansuy IM (2012) Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem 19:375–384. https://doi.org/10.1101/lm.027201.112
Lisman J, Yasuda R, Raghavachari S (2012) Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci 13:169–182. https://doi.org/10.1038/nrn3192
Mayford M, Wang J, Kandel ER, O’Dell TJ (1995) CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD and LTP. Cell 81:891–904. https://doi.org/10.1016/0092-8674(95)90009-8
Furman JL, Norris CM (2014) Calcineurin and glial signaling: neuroinflammation and beyond. J Neuroinflammation 11:158. https://doi.org/10.1186/s12974-014-0158-7
Kraner SD, Norris CM (2018) Astrocyte activation and the calcineurin/NFAT pathway in cerebrovascular disease. Front Aging Neurosci 10:287. https://doi.org/10.3389/fnagi.2018.00287
Lim D, Rocchio F, Lisa M, Fcancesco M (2016) From pathology to physiology of calcineurin signalling in astrocytes. Opera Medica et Physiol. https://doi.org/10.20388/OMP2016.002.0029
Tapella L, Soda T, Mapelli L et al (2019) Deletion of calcineurin from GFAP-expressing astrocytes impairs excitability of cerebellar and hippocampal neurons through astroglial Na+ /K+ ATPase. Glia. https://doi.org/10.1002/glia.23737
Lim D, Mapelli L, Canonico PL et al (2018) Neuronal activity-dependent activation of astroglial calcineurin in mouse primary hippocampal cultures. Int J Mol Sci. https://doi.org/10.3390/ijms19102997
Verkhratsky A, Parpura V, Vardjan N, Zorec R (2019) Physiology of astroglia. Adv Exp Med Biol 1175:45–91. https://doi.org/10.1007/978-981-13-9913-8_3
Verkhratsky A, Semyanov A, Zorec R (2020) Physiology of astroglial excitability. Function. https://doi.org/10.1093/function/zqaa016
Zorec R, Araque A, Carmignoto G et al (2012) Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route. ASN Neuro 4:e00080. https://doi.org/10.1042/AN20110061
Abbracchio MP, Ceruti S (2006) Roles of P2 receptors in glial cells: focus on astrocytes. Purinergic Signal 2:595–604. https://doi.org/10.1007/s11302-006-9016-0
Bradley SJ, Challiss RAJ (2012) G protein-coupled receptor signalling in astrocytes in health and disease: a focus on metabotropic glutamate receptors. Biochem Pharmacol 84:249–259. https://doi.org/10.1016/j.bcp.2012.04.009
Neurotransmitter Receptors in Astrocytes | SpringerLink. https://link.springer.com/chapter/https://doi.org/10.1007/978-0-387-79492-1_3. Accessed 27 Jun 2022
Parpura V, Verkhratsky A (2013) Astroglial amino acid-based transmitter receptors. Amino Acids 44:1151–1158. https://doi.org/10.1007/s00726-013-1458-4
Rivera A, Vanzulli I, Butt AM (2016) A central role for ATP signalling in glial interactions in the CNS. Curr Drug Targets 17:1829–1833. https://doi.org/10.2174/1389450117666160711154529
Spampinato SF, Copani A, Nicoletti F et al (2018) Metabotropic glutamate receptors in glial cells: a new potential target for neuroprotection? Front Mol Neurosci 11:414. https://doi.org/10.3389/fnmol.2018.00414
Prole DL, Taylor CW (2019) Structure and function of IP3 Receptors. Cold Spring Harb Perspect Biol 11:a035063. https://doi.org/10.1101/cshperspect.a035063
Okubo Y, Kanemaru K, Suzuki J et al (2019) Inositol 1,4,5-trisphosphate receptor type 2-independent Ca2+ release from the endoplasmic reticulum in astrocytes. Glia 67:113–124. https://doi.org/10.1002/glia.23531
Verkhratsky A, Untiet V, Rose CR (2019) Ionic signalling in astroglia beyond calcium. J Physiol (Lond). https://doi.org/10.1113/JP277478
Rose CR, Ziemens D, Verkhratsky A (2020) On the special role of NCX in astrocytes: translating Na+-transients into intracellular Ca2+ signals. Cell Calcium 86:102154. https://doi.org/10.1016/j.ceca.2019.102154
Rose CR, Karus C (2013) Two sides of the same coin: sodium homeostasis and signaling in astrocytes under physiological and pathophysiological conditions. Glia 61:1191–1205. https://doi.org/10.1002/glia.22492
Verkhratsky A, Rose CR (2020) Na+-dependent transporters: the backbone of astroglial homeostatic function. Cell Calcium 85:102136. https://doi.org/10.1016/j.ceca.2019.102136
Semyanov A (2019) Spatiotemporal pattern of calcium activity in astrocytic network. Cell Calcium 78:15–25. https://doi.org/10.1016/j.ceca.2018.12.007
Volterra A, Liaudet N, Savtchouk I (2014) Astrocyte Ca2+ signalling: an unexpected complexity. Nat Rev Neurosci 15:327–335. https://doi.org/10.1038/nrn3725
Savtchouk I, Carriero G, Volterra A (2018) Studying Axon-Astrocyte functional interactions by 3D two-photon Ca2+ imaging: a practical guide to experiments and “big data” analysis. Front Cell Neurosci 12:98. https://doi.org/10.3389/fncel.2018.00098
Bindocci E, Savtchouk I, Liaudet N et al (2017) Three-dimensional Ca2+ imaging advances understanding of astrocyte biology. Science. https://doi.org/10.1126/science.aai8185
Vardjan N, Parpura V, Zorec R (2016) Loose excitation-secretion coupling in astrocytes. Glia 64:655–667. https://doi.org/10.1002/glia.22920
Bootman MD, Chehab T, Bultynck G et al (2018) The regulation of autophagy by calcium signals: do we have a consensus? Cell Calcium 70:32–46. https://doi.org/10.1016/j.ceca.2017.08.005
Naranjo JR, Mellström B (2012) Ca2+-dependent transcriptional control of Ca2+ homeostasis. J Biol Chem 287:31674–31680. https://doi.org/10.1074/jbc.R112.384982
Oh-hora M, Rao A (2008) Calcium signaling in lymphocytes. Curr Opin Immunol 20:250–258. https://doi.org/10.1016/j.coi.2008.04.004
Puri BK (2020) Calcium signaling and gene expression. Adv Exp Med Biol 1131:537–545. https://doi.org/10.1007/978-3-030-12457-1_22
Molotkov D, Zobova S, Arcas JM, Khiroug L (2013) Calcium-induced outgrowth of astrocytic peripheral processes requires actin binding by Profilin-1. Cell Calcium 53:338–348. https://doi.org/10.1016/j.ceca.2013.03.001
Tanaka M, Shih P-Y, Gomi H et al (2013) Astrocytic Ca2+ signals are required for the functional integrity of tripartite synapses. Mol Brain 6:6. https://doi.org/10.1186/1756-6606-6-6
Rossi A, Pizzo P, Filadi R (2019) Calcium, mitochondria and cell metabolism: a functional triangle in bioenergetics. Biochim Biophys Acta Mol Cell Res 1866:1068–1078. https://doi.org/10.1016/j.bbamcr.2018.10.016
Augusto-Oliveira M, Arrifano GP, Takeda PY et al (2020) Astroglia-specific contributions to the regulation of synapses, cognition and behaviour. Neurosci Biobehav Rev 118:331–357. https://doi.org/10.1016/j.neubiorev.2020.07.039
Oliveira JF, Sardinha VM, Guerra-Gomes S et al (2015) Do stars govern our actions? astrocyte involvement in rodent behavior. Trends Neurosci 38:535–549. https://doi.org/10.1016/j.tins.2015.07.006
Carrión AM, Link WA, Ledo F et al (1999) DREAM is a Ca2+-regulated transcriptional repressor. Nature 398:80–84. https://doi.org/10.1038/18044
Wang H, Zhang M (2012) The role of Ca2+-stimulated adenylyl cyclases in bidirectional synaptic plasticity and brain function. Rev Neurosci 23:67–78. https://doi.org/10.1515/revneuro-2011-0063
Tapella L, Dematteis G, Ruffinatti FA et al (2021) Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer’s disease and epilepsy and predisposes to seizures. Cell Calcium 100:102480. https://doi.org/10.1016/j.ceca.2021.102480
Klee CB, Crouch TH, Krinks MH (1979) Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA 76:6270–6273
Wang JH, Desai R (1976) A brain protein and its effect on the Ca2+-and protein modulator-activated cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 72:926–932. https://doi.org/10.1016/s0006-291x(76)80220-3
Aramburu J, Rao A, Klee CB (2000) Calcineurin: from structure to function. Curr Top Cell Regul 36:237–295. https://doi.org/10.1016/s0070-2137(01)80011-x
Rusnak F, Mertz P (2000) Calcineurin: form and function. Physiol Rev 80:1483–1521. https://doi.org/10.1152/physrev.2000.80.4.1483
Miura E, Watanabe M (2022) Coexpression of calcineurin A and B subunits in various subcellular and synaptic compartments of cerebellar neurons and glia with particular abundance at parallel fiber-Purkinje cell synapses. Neurosci Res S0168–0102(22):00074–00078. https://doi.org/10.1016/j.neures.2022.02.007
Zeng H, Chattarji S, Barbarosie M et al (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107:617–629
Yáñez M, Gil-Longo J, Campos-Toimil M (2012) Calcium binding proteins. Adv Exp Med Biol 740:461–482. https://doi.org/10.1007/978-94-007-2888-2_19
Kakalis LT, Kennedy M, Sikkink R et al (1995) Characterization of the calcium-binding sites of calcineurin B. FEBS Lett 362:55–58. https://doi.org/10.1016/0014-5793(95)00207-p
Klee CB, Ren H, Wang X (1998) Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273:13367–13370. https://doi.org/10.1074/jbc.273.22.13367
Stemmer PM, Klee CB (1994) Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 33:6859–6866. https://doi.org/10.1021/bi00188a015
Creamer TP (2020) Calcineurin. Cell Commun Signal 18:137. https://doi.org/10.1186/s12964-020-00636-4
Yang SA, Klee CB (2000) Low affinity Ca2+-binding sites of calcineurin B mediate conformational changes in calcineurin A. Biochemistry 39:16147–16154. https://doi.org/10.1021/bi001321q
Shen X, Li H, Ou Y et al (2008) The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding. J Biol Chem 283:11407–11413. https://doi.org/10.1074/jbc.M708513200
Wang H, Du Y, Xiang B et al (2008) A renewed model of CNA regulation involving its C-terminal regulatory domain and CaM. Biochemistry 47:4461–4468. https://doi.org/10.1021/bi702539e
Li H, Rao A, Hogan PG (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 21:91–103. https://doi.org/10.1016/j.tcb.2010.09.011
Gal M, Li S, Luna RE et al (2014) The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin’s catalytic domain distant to the regulatory domain. Structure 22:1016–1027. https://doi.org/10.1016/j.str.2014.05.006
Brauer BL, Moon TM, Sheftic SR et al (2019) Leveraging new definitions of the LxVP SLiM to discover novel calcineurin regulators and substrates. ACS Chem Biol 14:2672–2682. https://doi.org/10.1021/acschembio.9b00606
Matsoukas M-T, Aranguren-Ibáñez Á, Lozano T et al (2015) Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners. Sci Signal. https://doi.org/10.1126/scisignal.2005918
Roy J, Cyert MS (2020) Identifying new substrates and functions for an old enzyme: calcineurin. Cold Spring Harb Perspect Biol 12:a035436. https://doi.org/10.1101/cshperspect.a035436
Sheftic SR, Page R, Peti W (2016) Investigating the human calcineurin interaction network using the πɸLxVP SLiM. Sci Rep 6:38920. https://doi.org/10.1038/srep38920
Wang L, Cheng N, Wang P et al (2020) A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin. J Biol Chem 295:2760–2770. https://doi.org/10.1074/jbc.RA119.010254
Wigington CP, Roy J, Damle NP et al (2020) Systematic discovery of short linear motifs decodes calcineurin phosphatase signaling. Mol Cell 79:342-358.e12. https://doi.org/10.1016/j.molcel.2020.06.029
Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI (1997) Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386:855–858. https://doi.org/10.1038/386855a0
Mehta S, Aye-Han N-N, Ganesan A et al (2014) Calmodulin-controlled spatial decoding of oscillatory Ca2+ signals by calcineurin. Elife 3:e03765. https://doi.org/10.7554/eLife.03765
Facchin F, Canaider S, Vitale L et al (2008) Identification and analysis of human RCAN3 (DSCR1L2) mRNA and protein isoforms. Gene 407:159–168. https://doi.org/10.1016/j.gene.2007.10.006
Mitchell AN, Jayakumar L, Koleilat I et al (2007) Brain expression of the calcineurin inhibitor RCAN1 (Adapt78). Arch Biochem Biophys 467:185–192. https://doi.org/10.1016/j.abb.2007.08.030
Porta S, Martí E, de la Luna S, Arbonés ML (2007) Differential expression of members of the RCAN family of calcineurin regulators suggests selective functions for these proteins in the brain. Eur J Neurosci 26:1213–1226. https://doi.org/10.1111/j.1460-9568.2007.05749.x
Mohmmad Abdul H, Baig I, Levine H et al (2011) Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric abeta in primary cell culture. Aging Cell 10:103–113. https://doi.org/10.1111/j.1474-9726.2010.00645.x
Wu H-Y, Tomizawa K, Oda Y et al (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 279:4929–4940. https://doi.org/10.1074/jbc.M309767200
Carmignoto G, Haydon PG (2012) Astrocyte calcium signaling and epilepsy. Glia 60:1227–1233. https://doi.org/10.1002/glia.22318
De Bock M, Decrock E, Wang N et al (2014) The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology. Biochim Biophys Acta 1843:2211–2232. https://doi.org/10.1016/j.bbamcr.2014.04.016
Koizumi S, Shigetomi E, Sano F et al (2021) Abnormal Ca2+ signals in reactive astrocytes as a common cause of brain diseases. Int J Mol Sci 23:149. https://doi.org/10.3390/ijms23010149
Lim D, Ronco V, Grolla AA et al (2014) Glial calcium signalling in Alzheimer’s disease. Rev Physiol Biochem Pharmacol 167:45–65. https://doi.org/10.1007/112_2014_19
Lim D, Rodríguez-Arellano JJ, Parpura V et al (2016) Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer’s disease. Curr Alzheimer Res 13:359–369
Mustaly-Kalimi S, Littlefield AM, Stutzmann GE (2018) Calcium signaling deficits in glia and autophagic pathways contributing to neurodegenerative disease. Antioxid Redox Signal 29:1158–1175. https://doi.org/10.1089/ars.2017.7266
Parpura V, Verkhratsky A (2013) Astrogliopathology: could nanotechnology restore aberrant calcium signalling and pathological astroglial remodelling? Biochim Biophys Acta 1833:1625–1631. https://doi.org/10.1016/j.bbamcr.2012.11.023
Verkhratsky A (2019) Astroglial calcium signaling in aging and Alzheimer’s disease. Cold Spring Harb Perspect Biol 11:a035188. https://doi.org/10.1101/cshperspect.a035188
Vincent AJ, Gasperini R, Foa L, Small DH (2010) Astrocytes in Alzheimer’s disease: emerging roles in calcium dysregulation and synaptic plasticity. J Alzheimers Dis 22:699–714. https://doi.org/10.3233/JAD-2010-101089
Dos Santos JPA, Vizuete AF, Gonçalves C-A (2020) Calcineurin-mediated hippocampal inflammatory alterations in streptozotocin-induced model of dementia. Mol Neurobiol 57:502–512. https://doi.org/10.1007/s12035-019-01718-2
Sompol P, Norris CM (2018) Ca2+, Astrocyte activation and Calcineurin/NFAT signaling in age-related neurodegenerative diseases. Front Aging Neurosci 10:199. https://doi.org/10.3389/fnagi.2018.00199
Gwack Y, Feske S, Srikanth S et al (2007) Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 42:145–156. https://doi.org/10.1016/j.ceca.2007.03.007
Abdul HM, Sama MA, Furman JL et al (2009) Cognitive decline in Alzheimer’s disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29:12957–12969. https://doi.org/10.1523/JNEUROSCI.1064-09.2009
Furman JL, Sama DM, Gant JC et al (2012) Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer’s disease. J Neurosci 32:16129–16140. https://doi.org/10.1523/JNEUROSCI.2323-12.2012
Furman JL, Sompol P, Kraner SD et al (2016) Blockade of astrocytic calcineurin/NFAT signaling helps to normalize hippocampal synaptic function and plasticity in a rat model of traumatic brain injury. J Neurosci 36:1502–1515. https://doi.org/10.1523/JNEUROSCI.1930-15.2016
Sompol P, Furman JL, Pleiss MM et al (2017) Calcineurin/NFAT signaling in activated astrocytes drives network hyperexcitability in Aβ-bearing mice. J Neurosci 37:6132–6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017
Dresselhaus EC, Meffert MK (2019) Cellular specificity of NF-κB function in the nervous system. Front Immunol 10:1043. https://doi.org/10.3389/fimmu.2019.01043
Mockenhaupt K, Gonsiewski A, Kordula T (2021) RelB and neuroinflammation. Cells 10:1609. https://doi.org/10.3390/cells10071609
Sochocka M, Diniz BS, Leszek J (2017) Inflammatory response in the CNS: friend or Foe? Mol Neurobiol 54:8071–8089. https://doi.org/10.1007/s12035-016-0297-1
Lim D, Iyer A, Ronco V et al (2013) Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia 61:1134–1145. https://doi.org/10.1002/glia.22502
Pons S, Torres-Aleman I (2000) Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 275:38620–38625. https://doi.org/10.1074/jbc.M004531200
Fernandez AM, Jimenez S, Mecha M et al (2012) Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer’s pathology. Mol Psychiatry 17:705–718. https://doi.org/10.1038/mp.2011.128
Fernandez AM, Hervas R, Dominguez-Fraile M et al (2016) Blockade of the interaction of calcineurin with FOXO in astrocytes protects against Amyloid-β-Induced neuronal death. J Alzheimers Dis 52:1471–1478. https://doi.org/10.3233/JAD-160149
Fernandez AM, Fernandez S, Carrero P et al (2007) Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci 27:8745–8756. https://doi.org/10.1523/JNEUROSCI.1002-07.2007
Ronco V, Grolla AA, Glasnov TN et al (2014) Differential deregulation of astrocytic calcium signalling by amyloid-β, TNFα, IL-1β and LPS. Cell Calcium 55:219–229. https://doi.org/10.1016/j.ceca.2014.02.016
Dineley KT, Hogan D, Zhang W-R, Taglialatela G (2007) Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 88:217–224. https://doi.org/10.1016/j.nlm.2007.03.010
Taglialatela G, Hogan D, Zhang W-R, Dineley KT (2009) Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95–99. https://doi.org/10.1016/j.bbr.2008.12.034
Taglialatela G, Rastellini C, Cicalese L (2015) Reduced incidence of dementia in solid organ transplant patients treated with calcineurin inhibitors. J Alzheimers Dis 47:329–333. https://doi.org/10.3233/JAD-150065
Beckner ME (2020) A roadmap for potassium buffering/dispersion via the glial network of the CNS. Neurochem Int 136:104727. https://doi.org/10.1016/j.neuint.2020.104727
Neusch C, Papadopoulos N, Müller M et al (2006) Lack of the Kir4.1 channel subunit abolishes K+ buffering properties of astrocytes in the ventral respiratory group: impact on extracellular K+ regulation. J Neurophysiol 95:1843–1852. https://doi.org/10.1152/jn.00996.2005
Larsen BR, Assentoft M, Cotrina ML et al (2014) Contributions of the Na+/K+-ATPase, NKCC1, and Kir4.1 to hippocampal K+ clearance and volume responses. Glia 62:608–622. https://doi.org/10.1002/glia.22629
Larsen BR, Stoica A, MacAulay N (2016) Managing brain extracellular K(+) during neuronal activity: the physiological role of the Na(+)/K(+)-ATPase subunit isoforms. Front Physiol 7:141. https://doi.org/10.3389/fphys.2016.00141
Dematteis G, Restelli E, Chiesa R et al (2020) Calcineurin controls expression of EAAT1/GLAST in mouse and human cultured astrocytes through dynamic regulation of protein synthesis and degradation. Int J Mol Sci. https://doi.org/10.3390/ijms21062213
Caudal LC, Gobbo D, Scheller A, Kirchhoff F (2020) The paradox of astroglial Ca2 + signals at the interface of excitation and inhibition. Front Cell Neurosci 14:609947. https://doi.org/10.3389/fncel.2020.609947
Aida T, Yoshida J, Nomura M et al (2015) Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice. Neuropsychopharmacology 40:1569–1579. https://doi.org/10.1038/npp.2015.26
Hotz AL, Jamali A, Rieser NN et al (2022) Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity. Glia 70:196–214. https://doi.org/10.1002/glia.24106
Bach ME, Hawkins RD, Osman M et al (1995) Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81:905–915. https://doi.org/10.1016/0092-8674(95)90010-1
Eichenbaum H (2017) On the integration of space, time, and memory. Neuron 95:1007–1018. https://doi.org/10.1016/j.neuron.2017.06.036
Sugar J, Moser M-B (2019) Episodic memory: neuronal codes for what, where, and when. Hippocampus 29:1190–1205. https://doi.org/10.1002/hipo.23132
Cheng J, Ji D (2013) Rigid firing sequences undermine spatial memory codes in a neurodegenerative mouse model. Elife 2:e00647. https://doi.org/10.7554/eLife.00647
Macêdo PT, Aquino ACQ, Meurer YSR et al (2018) Subtle alterations in spatial memory induced by amyloid peptides infusion in rats. Front Aging Neurosci 10:18. https://doi.org/10.3389/fnagi.2018.00018
Van Den Herrewegen Y, Denewet L, Buckinx A et al (2019) The barnes maze task reveals specific impairment of spatial learning strategy in the intrahippocampal kainic acid model for temporal lobe epilepsy. Neurochem Res 44:600–608. https://doi.org/10.1007/s11064-018-2610-z
Gallo FT, Katche C, Morici JF et al (2018) Immediate early genes, memory and psychiatric disorders: focus on c-Fos, Egr1 and Arc. Front Behav Neurosci 12:79. https://doi.org/10.3389/fnbeh.2018.00079
Ma H, Li B, Tsien RW (2015) Distinct roles of multiple isoforms of CaMKII in signaling to the nucleus. Biochim Biophys Acta 1853:1953–1957. https://doi.org/10.1016/j.bbamcr.2015.02.008
Mayford M, Bach ME, Huang YY et al (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678–1683. https://doi.org/10.1126/science.274.5293.1678
Kubik S, Miyashita T, Guzowski JF (2007) Using immediate-early genes to map hippocampal subregional functions. Learn Mem 14:758–770. https://doi.org/10.1101/lm.698107
Liu X-B, Murray KD (2012) Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia 53(Suppl 1):45–52. https://doi.org/10.1111/j.1528-1167.2012.03474.x
Filosa JA, Nelson MT, Gonzalez Bosc LV (2007) Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels. Am J Physiol, Cell Physiol 293:C1797-1805. https://doi.org/10.1152/ajpcell.00554.2006
Hsu W-L, Chung H-W, Wu C-Y et al (2015) Glutamate stimulates local protein synthesis in the axons of rat cortical neurons by activating α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) receptors and metabotropic glutamate receptors. J Biol Chem 290:20748–20760. https://doi.org/10.1074/jbc.M115.638023
Mabb AM (2021) Historical perspective and progress on protein ubiquitination at glutamatergic synapses. Neuropharmacology 196:108690. https://doi.org/10.1016/j.neuropharm.2021.108690
Weiler IJ, Hawrylak N, Greenough WT (1995) Morphogenesis in memory formation: synaptic and cellular mechanisms. Behav Brain Res 66:1–6. https://doi.org/10.1016/0166-4328(94)00116-w
Llanos-González E, Henares-Chavarino ÁA, Pedrero-Prieto CM et al (2019) Interplay between mitochondrial oxidative disorders and proteostasis in Alzheimer’s disease. Front Neurosci 13:1444. https://doi.org/10.3389/fnins.2019.01444
Olivero P, Lozano C, Sotomayor-Zárate R et al (2018) Proteostasis and mitochondrial role on psychiatric and neurodegenerative disorders: current perspectives. Neural Plast 2018:6798712. https://doi.org/10.1155/2018/6798712
Keren-Aviram G, Dachet F, Bagla S et al (2018) Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions. PLoS ONE 13:e0195639. https://doi.org/10.1371/journal.pone.0195639
Neuner SM, Wilmott LA, Hoffmann BR et al (2017) Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer’s disease mouse models. Behav Brain Res 322:288–298. https://doi.org/10.1016/j.bbr.2016.06.002
Sans MD, Williams JA (2004) Calcineurin is required for translational control of protein synthesis in rat pancreatic acini. Am J Physiol, Cell Physiol 287:C310-319. https://doi.org/10.1152/ajpcell.00534.2003
Aufschnaiter A, Kohler V, Büttner S (2017) Taking out the garbage: cathepsin D and calcineurin in neurodegeneration. Neural Regen Res 12:1776–1779. https://doi.org/10.4103/1673-5374.219031
Lapierre LR, Kumsta C, Sandri M et al (2015) Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 11:867–880. https://doi.org/10.1080/15548627.2015.1034410
Medina DL, Di Paola S, Peluso I et al (2015) Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 17:288–299. https://doi.org/10.1038/ncb3114
Pakos-Zebrucka K, Koryga I, Mnich K et al (2016) The integrated stress response. EMBO Rep 17:1374–1395. https://doi.org/10.15252/embr.201642195
Bollo M, Paredes RM, Holstein D et al (2010) Calcineurin interacts with PERK and dephosphorylates calnexin to relieve ER stress in mammals and frogs. PLoS ONE 5:e11925. https://doi.org/10.1371/journal.pone.0011925
Chen Y, Holstein DM, Aime S et al (2016) Calcineurin β protects brain after injury by activating the unfolded protein response. Neurobiol Dis 94:139–156. https://doi.org/10.1016/j.nbd.2016.06.011
Li H-H, Kedar V, Zhang C et al (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114:1058–1071. https://doi.org/10.1172/JCI22220
Mukherjee A, Soto C (2011) Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr Opin Cell Biol 23:223–230. https://doi.org/10.1016/j.ceb.2010.12.006
Shah SZA, Hussain T, Zhao D, Yang L (2017) A central role for calcineurin in protein misfolding neurodegenerative diseases. Cell Mol Life Sci 74:1061–1074. https://doi.org/10.1007/s00018-016-2379-7
Shimizu H, Langenbacher AD, Huang J et al (2017) The calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes. Elife. https://doi.org/10.7554/eLife.27955
Dematteis G, Restelli E, Vanella VV et al (2022) Calcineurin controls cellular prion protein expression in mouse astrocytes. Cells 11:609. https://doi.org/10.3390/cells11040609
Acknowledgements
This work had the following financial supports: grants 2013-0795 to AAG, 2014-1094 to D.L. from the Fondazione Cariplo; fellowship to LT from CRT Foundation (1393-2017); grants FAR-2016 and FAR-2019 to D.L. from The Università del Piemonte Orientale.
Funding
Open access funding provided by Università degli Studi del Piemonte Orientale Amedeo Avogrado within the CRUI-CARE Agreement. This work had the following financial supports: grants 2013–0795 to AAG, 2014–1094 to D.L. from the Fondazione Cariplo; fellowship to LT from CRT Foundation (1393–2017); grants FAR-2016 and FAR-2019 to D.L. from The Università del Piemonte Orientale.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. The first draft of the manuscript was written by Dmitry Lim and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lim, D., Tapella, L., Dematteis, G. et al. Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions. Neurochem Res 48, 1077–1090 (2023). https://doi.org/10.1007/s11064-022-03744-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-022-03744-4